~~<i id='648E09350C'><strike id='648E09350C'><tt id='648E09350C'><pre id='648E09350C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：knowledge 2025-09-05 05:07:11 - browse：424

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： The Bio Revolution is changing business and society

explore

focus

hotspot

knowledge

focus

AdobeThefederalgovernmentiscuttingtheaveragebenchmarkpaymentsfor2025MedicareAdvantageplansby0.2%,acc

WSS

Zyn nicotine pouches become unlikely player in latest culture war

J&J reports mixed data on next

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Unmasking the 'centricity' illusion in clinical trials

Clinicians often fail to acknowledge the pain caused by long Covid

hotspot

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Pancreatic cancer early detection could be helped by AI

Apple is now the first public company to be valued at $3 trillion

Some medical students still think black patients feel less pain

In age of alternative facts, a scholarly course on calling out crap

Congress: Prevent baby formula shortages by passing a new bill

Moonlake's readout produced a cash windfall. Risks remain

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

explore

FTC sues over Novant Health acquisition of two N.C. hospitals

The Affordable Care Act has saved billions in health care costs

Investment in vaccine development is lagging, report finds

Ozempic cut risk of death in diabetes patients with chronic kidney disease

10 reasons why health care startups fail

Vertex non

focus

hotspot

knowledge

focus